Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade.
Hama N, Kobayashi T, Han N, Kitagawa F, Kajihara N, Otsuka R, Wada H, Lee HK, Rhee H, Hasegawa Y, Yagita H, Baghdadi M, Seino KI. Hama N, et al. Among authors: seino ki. iScience. 2020 Sep 19;23(10):101584. doi: 10.1016/j.isci.2020.101584. eCollection 2020 Oct 23. iScience. 2020. PMID: 33205010 Free PMC article.
Erratum: Interleukin-34 Limits the Therapeutic Effects of Immune Checkpoint Blockade.
Hama N, Kobayashi T, Han N, Kitagawa F, Kajihara N, Otsuka R, Wada H, Lee HK, Rhee H, Hasegawa Y, Yagita H, Baghdadi M, Seino KI. Hama N, et al. Among authors: seino ki. iScience. 2022 Jan 5;25(1):103713. doi: 10.1016/j.isci.2021.103713. eCollection 2022 Jan 21. iScience. 2022. PMID: 35028541 Free PMC article.
Tumor-derived interleukin-34 creates an immunosuppressive and chemoresistant tumor microenvironment by modulating myeloid-derived suppressor cells in triple-negative breast cancer.
Kajihara N, Kobayashi T, Otsuka R, Nio-Kobayashi J, Oshino T, Takahashi M, Imanishi S, Hashimoto A, Wada H, Seino KI. Kajihara N, et al. Among authors: seino ki. Cancer Immunol Immunother. 2023 Apr;72(4):851-864. doi: 10.1007/s00262-022-03293-3. Epub 2022 Sep 14. Cancer Immunol Immunother. 2023. PMID: 36104597 Free PMC article.
Interleukin-34 cancels anti-tumor immunity by PARP inhibitor.
Nakamura T, Kajihara N, Hama N, Kobayashi T, Otsuka R, Han N, Wada H, Hasegawa Y, Suzuki N, Seino KI. Nakamura T, et al. Among authors: seino ki. J Gynecol Oncol. 2023 May;34(3):e25. doi: 10.3802/jgo.2023.34.e25. Epub 2022 Dec 21. J Gynecol Oncol. 2023. PMID: 36603850 Free PMC article.
Augmented interferon regulatory factor 7 axis in whole tumor cell vaccines prevents tumor recurrence by inducing interferon gamma-secreting B cells.
Kajihara N, Tanaka Y, Takeuchi R, Kobayashi T, Tanji M, Ataka T, Nakano S, Yamada T, Takaoka A, Hasegawa Y, Seino KI, Wada H. Kajihara N, et al. Among authors: seino ki. Oncoimmunology. 2023 May 22;12(1):2213132. doi: 10.1080/2162402X.2023.2213132. eCollection 2023. Oncoimmunology. 2023. PMID: 37235066 Free PMC article.
84 results